Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03980925
Title Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos

pancreatic endocrine carcinoma

neuroendocrine tumor

gastrointestinal neuroendocrine tumor


Carboplatin + Etoposide + Nivolumab

Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.